>
Organization
NeuroVive Pharmaceutical AB
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on NeuroVive Pharmaceutical AB

... Lund - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) informs on its scheduled company presentation ...
... An extraordinary general meeting was held in NeuroVive Pharmaceutical AB (publ) ('NeuroVive' or the 'Company'). A summary of the resolutions follows. ...
... Mitochondrial medicine company NeuroVive Pharmaceutical AB (STO:NVP) announced on Thursday that at the extraordinary general meeting, held ...
... today announced an increase of the number of shares and votes in NeuroVive of 126,235 as a result of a performed subscription options program (series ...
... Lund - NeuroVive Pharmaceutical AB (publ) ('NeuroVive' or 'the Company') announces adjustment of the following dates in the press ...
... email to Entitlement to participate and notification or, in writing to NeuroVive Pharmaceutical AB, Medicon Village, Scheelevagen 2, 223 81 Lund, Sweden, no later than ...
... and notify the company by email to or, in writing to NeuroVive Pharmaceutical AB, Medicon Village, Scheelevagen 2, 223 81 Lund, Sweden, no later than ...
... Stockholm: NVP, OTCQX: NEVPF) announces that the Board of Directors of NeuroVive Pharmaceutical AB (publ) ('NeuroVive' or 'the Company') on 10 December 2018 resolved, subject ...
... Lund - NeuroVive Pharmaceutical AB (publ) ('NeuroVive' or 'the Company') (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announces the outcome ...
... Mitochondrial medicine company NeuroVive Pharmaceutical AB (Neurovive) (STO:NVP) announced on Monday the outcome of the exercise of ...
Subscribe now for full coverage on NeuroVive Pharmaceutical AB
Start My Free Trial